Elizabeth Cohen reports on a milestone in embryonic stem cell research.
Two women with untreatable eye diseases said they had dramatic improvements in their vision after injections of human embryonic stem cells, making it the first documented time these controversial cells have helped someone.
For the first time, researchers have succeeded in creating human embryonic stem cells by injecting DNA from a skin cell into an unfertilized egg, according to a study published Wednesday.
There's great potential in the field of regenerative medicine, but doctors caution against seeking experimental treatments in an unregulated environment.
A federal judge dismissed a lawsuit Wednesday that tried to block funding of stem-cell research on human embryos.
"Pitcher's Treatment Draws Scrutiny," proclaimed the headline for this week's New York Times story about the medical treatment performed on New York Yankees pitcher Bartolo Colon's elbow and shoulder. The Web browser banner for the story was: "Disputed Treatment Used in Bartolo Colon's Comeback." Based on follow-up headlines across the sports world, the point of dispute is muddled at best and entirely misinterpreted at worst.
A federal appeals court has lifted a ban on federal funding for stem cell research.
A federal court has given the Obama administration the go-ahead to continue funding embryonic stem-cell research.
An international medical group has cleared a South Korean biopharmaceutical company in the deaths of two patients following stem cell procedures in other countries.
As you turn on your HDTV and watch the endless controversy over embryonic stem cell research, ask yourself: Should the government spend taxpayer dollars to develop that bulky old cathode-ray television you once owned?
In August, CNN's Jeffrey Toobin broke down what the stem cell ruling meant for the president and what happens next.
At one time in the Stem Cell Program at Children's Hospital in Boston, we had two liquid nitrogen containers, one labeled P, the other NP. These containers were used to store batches of stem cells.
The Justice Department, as promised, moved Tuesday to block a court ruling preventing use of government funds for embryonic stem cell research.
The Obama administration will appeal a federal judge's decision to temporarily block federal funding of embryonic stem cell research, Justice Department spokesman Matthew Miller confirmed Tuesday.
Administration officials are still reviewing a federal judge's decision to grant a preliminary injunction stopping federal funding of embryonic stem cell research, White House Deputy Press Secretary Bill Burton said Tuesday.
A U.S. district judge granted a preliminary injunction Monday to stop federal funding of embryonic stem cell research that he said destroys embryos, ruling it went against the will of Congress.
Diana Tirpak was so sure her leukemia was going to kill her, she bought a suit for her husband, Jake, to wear at her funeral.
If you've just had your first heart attack, doctors may one day be able to reverse the damage done with stem cell therapy.
13 human embryonic stem cell lines are approved for federally funded research.
Thirteen new human embryonic stem cell lines have been approved for use in federally funded research -- the first to be approved under an executive order from President Obama -- the National Institutes of Health announced Wednesday.
You know that fat in your body you wish you didn't have? It turns out those cells could be used to create stem cells that one day may be able to cure disease.
In a field largely still in its infancy, scientists are making headway toward using stem cells to treat heart ailments.
This Caribbean city already known for cigars, furniture, chocolate and coffee may become a magnet for Americans seeking controversial stem cell therapy for life-threatening illnesses if a Florida cardiologist has his way.
When it comes to stem cells, the public -- and the media -- tend to focus on embryos. But researchers and analysts say marketable therapies already are emerging from less controversial work with adult stem cells.
CNN's Drew Griffin reports on how stem cell therapy treatments overseas attract those desperate for a cure.
It's shortly after 5 a.m. when the phone rings, and on the line is a clearly anxious and worried parent.
The Obama administration released a draft of guidelines for federal funding of human embryonic stem cell research Friday.
President Obama signs an executive order repealing a Bush policy limiting federal money for embryonic stem cell research.
President Obama signed an executive order Monday repealing a Bush-era policy that limited federal tax dollars for embryonic stem cell research.
President Obama ends limits on stem cell research funding, saying it's time to end a false choice between morals, science.
A top congressional Republican on Sunday criticized President Barack Obama's expected decision to reverse the Bush administration's limits on embryonic stem-cell research, calling it a distraction from the country's economic slump.
President Obama is planning to sign an executive order Monday to overturn Bush-era policy that limited federal tax dollars for embryonic stem cell research, according to administration officials familiar with the deliberations.
The Food and Drug Administration has approved the first human clinical trial of embryonic stem cell therapy. The stem cells used for this study came from the 60 existing stem cell lines approved in August 2001 by the Bush administration. Before that time, federal research dollars were not allowed to be used for stem cell research.
Federal regulators have cleared the way for the first trials of human embryonic stem-cell research. Elizabeth Cohen reports.
Federal regulators have cleared the way for the first human trials of human embryonic stem-cell research, authorizing researchers to test whether the cells are safe to use in spinal injury patients, the company behind the trials announced Friday.
Stem cells are considered a holy grail of medical research. They are thought to hold immense potential for treating a wide range of diseases and disabilities.
As well as their potential for creating effective therapies for debilitating diseases, embryonic stem cells could open the door to improved pharmaceutical drug testing, according to a leading British stem cell researcher.
Researchers create the first nerve cells out of reprogrammed stem cells, using a technique that bypasses the destruction of embryos
The Food and Drug Administration looks like it's bowing to the inevitable this week and drawing the blueprint for the first-ever human experiments with human embryonic stem cells.
CNN's chief medical correspondent Dr. Sanjay Gupta discusses a new study that suggests alligator blood may have healing properties.
It sounds like the stuff of Stephen King -- generating body parts, repairing damaged bone and growing back muscle like a gecko's severed tail. But stem cells represent a new wave of medicine that is more science than science fiction. One day they may not only lengthen an athlete's career but also provide the quick healing that Yankees pitcher Andy Pettitte was looking for when he used HGH to recover from elbow tendinitis in 2002.
Whoever wins the White House, stem cell biotechs stand to reap the benefit from an incoming leader who is friendlier to stem cell researchers than President Bush, and that could lift stocks for the entire sector, experts say.
Leave it to MIT scientists to use a gecko as their muse for designing a bandage. CNN's Dr. Sanjay Gupta has more.
The first experiments using human embryonic stem cells in human subjects could begin within a few months, the chief executive of biotech Geron said Monday.
The stem-cell breakthrough doesn't make up for six years of hypocrisy and lost research
The recent breakthroughs in stem cell research, where adult cells were "reprogrammed" to act like embryonic stem cells, are too early-stage to have much influence on Big Pharma's venture capital investments, experts say.
The Harvard Stem Cell Institute's George Daley discusses the impact of a new stem cell finding on embryonic research.
All sides involved in the controversy over the use of embryonic stem cells in research claimed vindication Tuesday after two teams of researchers reported having reprogrammed human skin cells to act like the stem cells, which have the potential of morphing into other cells and thereby curing disease.
In a pair of landmark studies, two groups of scientists announced Tuesday that they have reprogrammed human skin cells to act like embryonic stem cells, whose potential to mature into any other kind of cell in the body may ultimately prove key to curing a number of diseases.
Ever wanted to be a new you? Recent developments in cloning mean that day might be possible without therapy, a new diet or fitness regime.
Companies that develop drugs using embryonic stem cell research could soon enter a bold new phase: human testing.
What do you think the future holds for health? What developments are you hoping for? What challenges will we face? Send us your thoughts and we'll print the best ones here.
The questionable stem cells created by a disgraced Korean researcher turn out to be a bona fide medical breakthrough
Early-stage studies in mice have shown that adult blood could be a richer source of insulin-creating stem cells than fertilized eggs, according to Dr. Yong Zhao, assistant professor at the University of Illinois.
Pushing back against the Democratic-led Congress, President Bush vetoed a bill Wednesday that would have eased restraints on federally funded embryonic stem cell research
Is George W. Bush right to veto the easing of federal funding restrictions on stem cell research?
The latest findings may expand the ways of generating customized stem cells -- and defuse the ethical objections
A California company now offers IVF patients the option of creating and storing their own stem cells
Some of the biotechs specializing in stem cell research took a hit Thursday after the Senate voted to remove a ban on federal funding for embryonic stem cell research but not by a wide enough margin to overcome an expected presidential veto.
The Senate turned its attention to plans to loosen President Bush's 2001 limits on embryonic stem-cell research Tuesday, but sponsors conceded their chances of overriding a threatened veto are uncertain.
Two new stem cell treatments could be entering the U.S. market next year.
The U.S. House of Representatives voted in favor of a bill that would lift President Bush's funding restrictions on research involving embryonic stem cells.
Stock prices for biotechs involved in stem cell technology continued to surge Monday, after soaring the prior week, after a new source of stem cells was announced, and as the House prepares to vote on whether to loosen federal funding for research involving embryonic stem cells.
Last year, Hwang Woo-suk was Korea's scientific Superman. He had three institutes, a stamp created in his honor, and, over the years, $60 million at his disposal. His face was plastered on buses in...
It is a country where the call to prayer echoes throughout the capital every morning, where women must cover their heads at all times, where a Supreme Leader has the final say over everything.
The winners and losers from the mid-term elections weren't limited to the candidates on the ballots.
Voters in six states Tuesday approved ballot measures raising the minimum wage, joining 18 other states in setting a wage higher than the federal mark of $5.15 an hour, according to CNN projections.
The results of Missouri's referendum on stem cell research Tuesday could impact several biotechs specializing in that line of work.
After a nearly 20-year absence, Nixon-loving, Reagan-worshipping Alex P. Keaton is again slinging his political views on television.
Some key dates surrounding moral issues:
Moral issues sometimes drive voters to the polls not only to support or oppose a candidate, but also to make their voices heard on dozens of ballot measures dealing with issues like same-sex marriage, abortion or stem cell research.
Embryonic stem cells might hold the secrets to curing paralysis and brain damage, but they've also garnered plenty of controversy with the anti-abortion lobby because they're harvested from embryos.
In July, George W. Bush quashed a bill to fund stem cell research, his first veto as President. The issue should loom large come November. Here's the impact on U.S. biotech.
To its advocates, including British Prime Minister Tony Blair and Californian Governor Arnold Schwarzenegger, stem cell therapies promise a medical revolution that will enable all of us to live longer, healthier lives.
Stem-cell research has joined global warming and evolution science as fields in which the very facts are put to a vote, a public spectacle in which data wrestle dogma.
Geron Corp.'s stock price rose significantly after the biotech announced that its experimental, stem-cell-based therapy for spinal cord injuries is safe in rats.
President Bush used his veto power Wednesday for the first time since taking office 5 1/2 years ago, saying that an embryonic stem-cell research bill "crossed a moral boundary."
George W. Bush seldom suffered personally from doing what's unpopular politically. In fact, you could argue that he has made a career of it, holding fast to positions that many voters reject, as a sign of strength in these dangerous times. So his willingness to exercise his first-ever veto this week on a bill that would expand federal funding for human embryonic-stem-cell research, which 2 out of 3 voters favor, is not just a way to stroke his political base. "People like leadership much better than a finger in the wind," says White House press secretary Tony Snow. As Bush explained to him while in St. Petersburg, Russia, for the G-8 summit last week, "I took a position. I believe in it. So that's what I'm going to do."
Senate Majority Leader Bill Frist introduced a bill Thursday to expand funding for embryonic stem cell research and said it would be debated and voted on in July.
Paralyzed rats are walking again, thanks to a new stem cell treatment; that's big news for the medical community ... and a 10-year wait for anybody wanting to make a buck off it.
Paralyzed rats partially regained the use of a previously immobile hind leg in a study in which scientists injected the rodents with stem cells from mouse embryos, according to researchers at Johns Hopkins University.
Celgene Corp., a biotech specializing in stem cell research, patented its methods for recovering stem cells from a human placenta after birth, the company said.
The panel for the first CNN Future Summit program is set. Originating from Singapore, the one hour program will focus on the long-term impact of research into the fields of robotics, cybernetics, genetics and stem cells.
Despite the controversies surrounding it, stem cell research is already changing lives. In the future, it offers hope for cures and treatments for a variety of diseases and disorders. We want to know what you think about the promise of stem cell research.
Chances are very good you've heard about stem cells. Whether from reports of their almost miraculous ability to cure and restore, or very public controversies over their source or the research itself, stem cells have been a hot topic in the news for years.
British scientists are seeking permission to create hybrid embryos by fusing human cells with rabbit eggs.
Disgraced South Korean cloning scientist Hwang Woo-suk has apologized for publishing fake research on human stem cells, but said he was deceived by researchers at another lab.
South Korea's top university on Wednesday apologized for the scandal over Hwang Woo-suk's faked stem cell research, calling it a blemish on the country that embraced the scientist as a national hero.
One day after a panel investigating the work of disgraced South Korean scientist Hwang Woo-suk found that he faked claims of cloning human embryonic stem cells, the Seoul National University has issued a public apology.
A panel investigating the work of disgraced South Korean scientist Hwang Woo-suk has found that he faked claims of cloning human embryonic stem cells, in what could be the biggest cover-up in modern scientific history.
An expert panel from Seoul National University has dealt another blow to scientific claims by former researcher Hwang Woo-suk, saying he did not produce patient-specific stem cells as he had claimed in a landmark research paper.
An expert panel from Seoul National University has said that South Korean researcher Hwang Woo-suk falsified results of nine of 11 stem cell lines he claimed to have created, casting more doubts on breakthrough claims he made in the U.S. journal Science in May.
Former "Baywatch" star Brooke Burns, who broke her neck last month after diving into her backyard pool, credits a friend, a paramedic firefighter, with saving her life.
It may not be your average Christmas present or gift for a newborn baby, but a British-based company says grandparents looking for a gift with a twist are increasingly investing in stem cells for their grandchildren.
A prominent South Korean scientist is defending himself against allegations of fraud in the already controversial field of stem-cell research.
Hawaiian crooner Don Ho, who had an experimental procedure on his ailing heart earlier this week, says he's feeling much better and may return home to the islands within a few days.
Denise Villani was told she had a cancer that could not be cured, but three and a half years on, after taking part in a clinical trial for a vaccine, she is cancer-free. This is her story: